Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells
- PMID: 19723057
- DOI: 10.1111/j.1749-6632.2009.04913.x
Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells
Abstract
Cyclopentenone prostaglandins (cyPGs) exert diverse cellular functions, such as anti-inflammatory and cytoprotective effects, via multiple mechanisms. CyPGs, especially those of the A and J series, are characterized by the presence of a chemically reactive alpha,beta-unsaturated carbonyl group. 15-Deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)), a representative cyPG of the J series, has been reported to directly inhibit the activity of redox-sensitive transcription factors, such as activator protein-1 and nuclear factor-kappaB. In the present study, we examined the effects of 15d-PGJ(2) on activation of p53 tumor suppressor in human breast cancer (MCF-7) cells. MCF-7 cells treated with 15d-PGJ(2) exhibited elevated p53 protein expression in time- and concentration-related manners, whereas prostaglandin A(2) (PGA(2)) and the nonprostaglandin derivative 2-cyclopenten-1-one exerted an effect to a lesser extent than did 15d-PGJ(2). In addition, MCF-7 cells exposed to 15d-PGJ(2) significantly accumulated p53 in both cytosolic and nuclear fractions. Despite the elevated levels of p53, its DNA-binding activity was reduced in 15d-PGJ(2)-treated MCF-7 cells. Moreover, isolated MCF-7 nuclear extracts directly treated with 15d-PGJ(2) exhibite diminished DNA-binding ability of p53, while the same concentration of PGA(2) or 2-cyclopenten-1-one was much less inhibitory. Thus, the electrophilic carbon center located in the alpha,beta-unsaturated carbonyl moiety of the cyclopentenone ring might be critical for the control of DNA-binding activity as well as cellular levels of p53 by 15d-PGJ(2).
Similar articles
-
15-Deoxy-delta 12, 14-prostaglandin J2 induces upregulation of multidrug resistance-associated protein 1 via Nrf2 activation in human breast cancer cells.Ann N Y Acad Sci. 2009 Aug;1171:210-6. doi: 10.1111/j.1749-6632.2009.04914.x. Ann N Y Acad Sci. 2009. PMID: 19723058
-
15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue.Oncogene. 2010 Apr 29;29(17):2560-76. doi: 10.1038/onc.2010.8. Epub 2010 Mar 8. Oncogene. 2010. PMID: 20208557
-
Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.Chem Res Toxicol. 2011 Aug 15;24(8):1231-41. doi: 10.1021/tx200090n. Epub 2011 Jul 25. Chem Res Toxicol. 2011. PMID: 21728338
-
15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.Biochem Pharmacol. 2006 Nov 30;72(11):1516-28. doi: 10.1016/j.bcp.2006.07.030. Epub 2006 Sep 20. Biochem Pharmacol. 2006. PMID: 16987499 Review.
-
15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses.Chem Res Toxicol. 2008 Jan;21(1):138-44. doi: 10.1021/tx700177j. Epub 2007 Dec 4. Chem Res Toxicol. 2008. PMID: 18052108 Review.
Cited by
-
Breaking the paradigm: Dr Insight empowers signature-free, enhanced drug repurposing.Bioinformatics. 2019 Aug 15;35(16):2818-2826. doi: 10.1093/bioinformatics/btz006. Bioinformatics. 2019. PMID: 30624606 Free PMC article.
-
Untargeted metabolomics profiling in a mouse model of lung cancer treated with thermal ablation.Bioengineered. 2022 Apr;13(4):11258-11268. doi: 10.1080/21655979.2022.2065742. Bioengineered. 2022. PMID: 35481548 Free PMC article.
-
15d-PGJ2 is a new hope for controlling tumor growth.Am J Transl Res. 2018 Mar 15;10(3):648-658. eCollection 2018. Am J Transl Res. 2018. PMID: 29636856 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous